Pharma Focus Asia
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

30

Jun 2020

VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical

VITRAC Therapeutics LLC VITRAC initiated the global clinical development of VIC an oncology candidate formally known as TAS which was licensed from Taiho Pharmaceutical Co Ltd Taiho a Japanbased oncology company Two Phase clinical studies have been conducted in the US and Europe by Taiho VITRAC obta...

30

Jun 2020

Biocare Medical and Bethyl Laboratories Announce Strategic Partnership for Antibody Development

Biocare Medical a leading provider of innovative automated immunohistochemistry IHC reagents and instrumentation announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics

29

Jun 2020

SFA Therapeutics Announces FDA Approval To Begin IND Trial

SFA Therapeutics Inc is pleased to announce that the US FDA has provided approval to conduct a clinical trial officially referred to as an IND for the treatment of the appearance of the structure of skin with plaques due to psoriasis SFA plans to expand the evaluation of one of its five microbiomed...

29

Jun 2020

Nordic Nanovector's Betalutin® Receives Fast-track Designation from US FDA for Marginal Zone Lymphoma

Nordic Nanovector ASA announces that the US Food and Drug Administration FDA has granted Fast Track designation for investigating Betalutin Lu lilotomab satetraxetan for the treatment of adult patients with relapsed or refractory marginal zone lymphoma MZL who have received at least two prior system...

27

Jun 2020

Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

Axsome Therapeutics Inc a biopharmaceutical company developing novel therapies for the management of central nervous system CNS disorders announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for AXS for the treatment of Alzheimers disease AD agitation A...

26

Jun 2020

Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate

Moderna Inc a clinical stage biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines to create a new generation of transformative medicines for patients and Catalent Inc NYSE CTLT the leading global provider of advanced delivery technologies development and manufacturing soluti...

26

Jun 2020

Aldevron Announces Agreement with Ziopharm Oncology for neoGMP® Production of Sleeping Beauty Plasmid DNA to Express TCRs for Treatment of Solid Tumors

Aldevron a leading provider of products and services for the biotechnology industry announced an agreement with Ziopharm Oncology to produce plasmid DNA for T cell therapy of solid tumors Aldevron has developed the neoGMP service level designed to address this new and rapidly growing market

press releasesRead more...

30

Jun 2020

RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19

RevImmune a privately held biotechnology company developing CYT immune therapy for infectious diseases and cancer announced that it has launched the ILIAD Phase II trial for treatment of COVID

30

Jun 2020

IPA Confirms Discovery of Fully Human, Potent, Neutralizing Antibodies Targeting SARS-CoV-2

IMMUNOPRECISE ANTIBODIES LTD an experienced leader in fullservice therapeutic antibody discovery and development announced the identification of numerous lead candidate antibodies with highlypotent neutralizing activity in vitro which are being manufactured for further testing and possible inclusion...

30

Jun 2020

Novartis announces MET inhibitor Tabrecta™ approved in Japan for advanced non-small cell lung cancer with METex14

Novartis Pharma KK today announced that the Japanese Ministry of Health Labour and Welfare MHLW approved Tabrecta capmatinib formerly INC an oral MET inhibitor for MET exon skipping METex mutationpositive advanced andor recurrent unresectable nonsmall cell lung cancer NSCLC Tabrecta is approved for...

30

Jun 2020

GSK receives first regulatory approval for Duvroq (daprodustat) in Japan for patients with anaemia due to chronic kidney disease

GlaxoSmithKline plc announced the approval of a Japanese New Drug Application JNDA by the Ministry of Health Labour and Welfare for Duvroq daprodustat tablets an oral hypoxiainducible factor prolyl hydroxylase inhibitor HIFPHI for the treatment of patients with anaemia due to chronic kidney disease...

30

Jun 2020

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer

Merck known as MSD outside the United States and Canada today announced that the US Food and Drug Administration FDA has approved KEYTRUDA Mercks antiPD therapy as monotherapy for the firstline treatment of patients with unresectable or metastatic microsatellite instabilityhigh MSIH or mismatch repa...

30

Jun 2020

Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorder

Roche announced today that Japans Ministry of Health Labour and Welfare MHLW has approved ENSPRYNG satralizumab for the prevention of relapses of neuromyelitis optica spectrum disorder NMOSD including NMO for aquaporin antibody AQPIgG seropositive adults and children ENSPRYNG demonstrated robust eff...

30

Jun 2020

FDA approves Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer

Roche announced that the US Food and Drug Administration FDA has approved Phesgo a fixeddose combination of Perjeta pertuzumab and Herceptin trastuzumab with hyaluronidase administered by subcutaneous SC under the skin injection in combination with intravenous IV chemotherapy for the treatment of ea...

EventsRead more...

06 - 09

Jul 2020

Transcription Factor Drug Development Congress

-

08 - 09

Jul 2020

Hospice care and Palliative Care

Allied Conferences
Amsterdam

08 - 09

Jul 2020

Pain Management: Issues, Challenges & Treatment

Allied Conferences
Amsterdam

13 - 13

Jul 2020

Plenareno Depression Conference 2020

Plenareno
Dubai

13 - 13

Jul 2020

Virtual Patient Experience Innovation Summit

-

13 - 14

Jul 2020

Plenareno Heart Congress 2020

Radisson Blu Dubai

14 - 15

Jul 2020

22nd World Congress on Toxicology and Pharmacology

Conference Series LLC ltd
Kyoto

14 - 15

Jul 2020

Cancer Science and Therapy

Rome

Advertisements

Syntegon - The numbers speak for themselves
Swiss World Cargo - Osaka
Meco - 90 years
AI - Placement
Eclinical - Placement
Marketing Research - Placement

TOP ARTICLES

  • 4

    Laser Vaccine Adjuvants

     Vaccine adjuvants represent an essential tool to augment human immune response Despite significant advances in...

KNOWLEDGE BANK

  • Articles

    Electronic Counters for Bottle Filling

    When a label on a bottle says tablets we assume there are tablets inside dont we Not or but exactly To be more precise it is expected that the bottle contains exactly undamaged tablets of the same kind Obviously bottle filling technology must meet two bigger requirements namely high accuracy filling and the quality of filled products

  • White Papers

    Taking Fill Release Rates To A New Level

    Summary Gelatine capsules are among the most popular single unit dosage forms for drugs Rx overthecounter OTC products and food supplements While hard gelatine capsules are primarily used for powder applications soft gelatine capsules are the preferred dosage form for liquid pastelike or oilbased active ingredients In general soft shell capsules r

Advisory Board

Stella Stergiopoulos

Stella
Sanjoy Ray

Sanjoy Ray
Rustom Mody

Rustom
Phil Kaminsky

Phil
Neil J Campbell

Neil J
Laurence Flint

Laurence
Kenneth I Kaitin

Kenneth I
Georg C Terstappen

Georg C
Frank A Jaeger

Frank A
Douglas Meyer

Douglas
Christopher-Paul Milne

Christopher-
Alan S Louie

Alan S Louie

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...